FFCP PHASE1:Hg19::chr2:196313239..196313248,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=-7bp_to_ENST00000413290_5end | |||
|cluster_id=chr2:196313239..196313248,+ | |||
|coexpression_cluster_id=C191 | |||
|description=CAGE_peak_1_at_ENST00000413290_5end | |||
|id=chr2:196313239..196313248,+ | |||
|ontology_enrichment_celltype=CL:0002127!4.61e-26!1;CL:0000914!4.61e-26!1;CL:0000911!4.61e-26!1;CL:0000814!4.61e-26!1;CL:0002042!4.61e-26!1;CL:0002039!4.61e-26!1;CL:0002040!4.61e-26!1;CL:0002041!4.61e-26!1;CL:0000819!9.79e-26!1;CL:0000893!9.40e-14!2;CL:0002489!9.40e-14!2;CL:0000809!9.40e-14!2;CL:0000808!9.40e-14!2;CL:0000894!9.40e-14!2;CL:0000806!9.40e-14!2;CL:0000807!9.40e-14!2;CL:0000805!9.40e-14!2;CL:0002425!9.40e-14!2;CL:0000785!1.37e-13!2;CL:0000955!1.37e-13!2;CL:0000818!1.37e-13!2;CL:0000954!1.37e-13!2;CL:0000816!1.37e-13!2;CL:0000945!6.10e-10!24;CL:0000826!6.10e-10!24;CL:0000817!1.67e-09!3;CL:0000838!4.90e-08!52;CL:0000542!6.84e-08!53;CL:0000051!6.84e-08!53;CL:0000083!1.49e-07!4 | |||
|ontology_enrichment_celltype_v019=CL:0002127;2.21e-40;1!CL:0000911;2.21e-40;1!CL:0000814;2.21e-40;1!CL:0000083;3.42e-11;4 | |||
|ontology_enrichment_celltype_v019_2=CL:0002127,2.21e-40,1;CL:0000914,2.21e-40,1;CL:0000911,2.21e-40,1;CL:0000814,2.21e-40,1;CL:0002042,2.21e-40,1;CL:0002039,2.21e-40,1;CL:0002040,2.21e-40,1;CL:0002041,2.21e-40,1;CL:0000893,5.70e-21,2;CL:0002489,5.70e-21,2;CL:0000809,5.70e-21,2;CL:0000808,5.70e-21,2;CL:0000894,5.70e-21,2;CL:0000806,5.70e-21,2;CL:0000807,5.70e-21,2;CL:0000805,5.70e-21,2;CL:0002425,5.70e-21,2;CL:0000083,3.10e-11,4 | |||
|ontology_enrichment_development_v019=CL:0002425;5.69e-21;2 | |||
|ontology_enrichment_disease=DOID:0060073!9.79e-26!1;DOID:8675!9.79e-26!1;DOID:4074!8.28e-14!2;DOID:4905!8.28e-14!2;DOID:3498!8.28e-14!2;DOID:0060058!6.61e-11!10;DOID:2531!3.33e-08!51;DOID:0060083!3.33e-08!51;DOID:1793!1.49e-07!4 | |||
|ontology_enrichment_disease_v019=DOID:4074;5.69e-21;2!DOID:4905;5.69e-21;2!DOID:3498;5.69e-21;2!DOID:1793;3.42e-11;4!DOID:170;6.78e-08;6 | |||
|ontology_enrichment_disease_v019_2=DOID:4074,4.66e-21,2;DOID:4905,4.66e-21,2;DOID:3498,4.66e-21,2;DOID:1793,3.10e-11,4;DOID:170,6.34e-08,6 | |||
|ontology_enrichment_uberon=UBERON:0002370!1.59e-07!4;UBERON:0005058!1.59e-07!4;UBERON:0009113!1.59e-07!4;UBERON:0003295!1.59e-07!4;UBERON:0005562!1.59e-07!4 | |||
|ontology_enrichment_uberon_v019=UBERON:0000945;3.22e-09;5!UBERON:0010039;3.22e-09;5 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002370,3.42e-11,4;UBERON:0005058,3.42e-11,4;UBERON:0009113,3.42e-11,4;UBERON:0003295,3.42e-11,4;UBERON:0005562,3.42e-11,4;UBERON:0003351,6.78e-08,6;UBERON:0004177,6.04e-07,7;UBERON:0005057,6.04e-07,7 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0787107813136792,0,0,0,0,0,0,2.47895041856965,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.90544744788996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.540911356951966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.182454789215666,0,1.94224303627274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.37443915399099,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.83110221544025,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@ENST00000413290 | |||
}} |
Latest revision as of 04:33, 29 July 2015
Short description: | p1@ENST00000413290 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_ENST00000413290_5end |
Coexpression cluster: | C191_leiomyoblastoma_Mast_parietal_acute_bone_neuroepithelioma_embryonic |
Association with transcript: | -7bp_to_ENST00000413290_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
innate effector T cell | 2.21e-40 | 1 |
immature NK T cell | 2.21e-40 | 1 |
effector T cell | 2.21e-40 | 1 |
mature NK T cell | 2.21e-40 | 1 |
immature NK T cell stage IV | 2.21e-40 | 1 |
immature NK T cell stage I | 2.21e-40 | 1 |
immature NK T cell stage II | 2.21e-40 | 1 |
immature NK T cell stage III | 2.21e-40 | 1 |
thymocyte | 5.70e-21 | 2 |
double negative thymocyte | 5.70e-21 | 2 |
double-positive, alpha-beta thymocyte | 5.70e-21 | 2 |
DN4 thymocyte | 5.70e-21 | 2 |
DN1 thymic pro-T cell | 5.70e-21 | 2 |
DN2 thymocyte | 5.70e-21 | 2 |
DN3 thymocyte | 5.70e-21 | 2 |
immature single positive thymocyte | 5.70e-21 | 2 |
early T lineage precursor | 5.70e-21 | 2 |
epithelial cell of pancreas | 3.10e-11 | 4 |
Ontology term | p-value | n |
---|---|---|
thymus | 3.42e-11 | 4 |
hemolymphoid system gland | 3.42e-11 | 4 |
thymic region | 3.42e-11 | 4 |
pharyngeal gland | 3.42e-11 | 4 |
thymus primordium | 3.42e-11 | 4 |
pharyngeal epithelium | 6.78e-08 | 6 |
hemopoietic organ | 6.04e-07 | 7 |
immune organ | 6.04e-07 | 7 |
Ontology term | p-value | n |
---|---|---|
pancreas adenocarcinoma | 4.66e-21 | 2 |
pancreatic carcinoma | 4.66e-21 | 2 |
pancreatic ductal adenocarcinoma | 4.66e-21 | 2 |
pancreatic cancer | 3.10e-11 | 4 |
endocrine gland cancer | 6.34e-08 | 6 |